Research has shown that the application of PARP-1 inhibitor AG14361 on breast cancer cell lines, which constitutively express NF-kB, successfully suppressed the expression of a luciferase reporter gene activated by ionizing radiation. The gene discussed is PARP1; the disease is breast carcinoma.